Literature DB >> 29694238

How Many FOXs Are There on The Road to Pulmonary Hypertension?

Kurt R Stenmark1,2,3, Cheng-Jun Hu3,4, Soni S Pullamsetti5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29694238      PMCID： PMC6222465          DOI： 10.1164/rccm.201804-0702ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  12 in total

Review 1.  FOXOs: signalling integrators for homeostasis maintenance.

Authors:  Astrid Eijkelenboom; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-17       Impact factor: 94.444

Review 2.  Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).

Authors:  Soni S Pullamsetti; Frédéric Perros; Prakash Chelladurai; Jason Yuan; Kurt Stenmark
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

3.  Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.

Authors:  Rajkumar Savai; Hamza M Al-Tamari; Daniel Sedding; Baktybek Kojonazarov; Christian Muecke; Rebecca Teske; Mario R Capecchi; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly; Soni Savai Pullamsetti
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

Review 4.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

5.  Hypoxia-induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1.

Authors:  Aarti Raghavan; Guofei Zhou; Qiyuan Zhou; Joyce Christina F Ibe; Ramaswamy Ramchandran; Qiwei Yang; Harini Racherla; Pradip Raychaudhuri; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-27       Impact factor: 6.914

6.  FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.

Authors:  Alice Bourgeois; Caroline Lambert; Karima Habbout; Benoit Ranchoux; Stéphanie Paquet-Marceau; Isabelle Trinh; Sandra Breuils-Bonnet; Renée Paradis; Valérie Nadeau; Roxane Paulin; Steeve Provencher; Sébastien Bonnet; Olivier Boucherat
Journal:  J Mol Med (Berl)       Date:  2017-12-30       Impact factor: 4.599

Review 7.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 8.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

9.  FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation.

Authors:  Arunima Sengupta; Vladimir V Kalinichenko; Katherine E Yutzey
Journal:  Circ Res       Date:  2012-11-14       Impact factor: 17.367

Review 10.  Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.

Authors:  Angelo D'Alessandro; Karim C El Kasmi; Lydie Plecitá-Hlavatá; Petr Ježek; Min Li; Hui Zhang; Sachin A Gupte; Kurt R Stenmark
Journal:  Antioxid Redox Signal       Date:  2017-08-14       Impact factor: 8.401
View more
  3 in total

Review 1.  The multifaceted roles of FOXM1 in pulmonary disease.

Authors:  Yumei Li; Feng Wu; Qi Tan; Mengfei Guo; Pei Ma; Xuan Wang; Shuai Zhang; Juanjuan Xu; Ping Luo; Yang Jin
Journal:  Cell Commun Signal       Date:  2019-04-16       Impact factor: 5.712

Review 2.  Genetic Delivery and Gene Therapy in Pulmonary Hypertension.

Authors:  Nabham Rai; Mazen Shihan; Werner Seeger; Ralph T Schermuly; Tatyana Novoyatleva
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

3.  Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.

Authors:  Fei Sun; Guolun Wang; Arun Pradhan; Kui Xu; Jose Gomez-Arroyo; Yufang Zhang; Gregory T Kalin; Zicheng Deng; Ronald J Vagnozzi; Hua He; Andrew W Dunn; Yuhua Wang; Allen J York; Rashmi S Hegde; Jason C Woods; Tanya V Kalin; Jeffery D Molkentin; Vladimir V Kalinichenko
Journal:  Circulation       Date:  2021-06-11       Impact factor: 39.918
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.